https://www.selleckchem.com/products/vx-561.html
Extracellular vesicles (EVs) released by blood cells have proinflammation and procoagulant action. Patients with systemic lupus erythematosus (SLE) present high vascular inflammation and are prone to develop cardiovascular diseases. Therefore, we postulated that the EV populations found in blood, including platelet EVs (PEVs) and red blood cell EVs (REVs), are associated with SLE disease activity and SLE-associated cardiovascular accidents. We assessed autotaxin (ATX) plasma levels by ELISA, the platelet activation markers PAC1 and CD62P
Like
Comment
Share
